Jump Financial’s Korro Bio KRRO Stock Holding History

Jump Financial’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-505	Closed	-$54K	–	1824
2022 Q1	$54K	Buy	505 +199	+65%	+$38K	﹤0.01%	1465
2021 Q4	$78K	Buy	+306	New	+$93K	﹤0.01%	1257

Other funds holding KRRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Financial's KRRO Position: Q2 2022 in Review

Jump Financial sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 505 shares — an estimated $54K sold.

Jump Financial first reported a position in KRRO in Q4 2021 and held it in 2 quarters. The position peaked at $78K in Q4 2021. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

Jump Financial reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
Jump Financial sold 505 Korro Bio shares in Q2 2022, an estimated $54K.
Jump Financial first reported a position in Korro Bio in Q4 2021 and held it in 2 quarters.
Jump Financial's Korro Bio position peaked at $78K in Q4 2021.
58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on Jump Financial's 13F filing for Q2 2022, filed 9 Aug 2022.